Text/Yangcheng Evening News all-media reporter Zhang Hua
Photo/Visual China
With the progression of type 2 diabetes, the patient's islet β cell function is reduced and insulin resistance increases, and long-term hyperglycemia and its complications have seriously endangered the patient's quality of life.
It is understood that for patients with acute complications, insulin therapy needs to be activated in time, while dynamically monitoring blood glucose and vital signs, and adjusting the treatment plan in real time. For patients with chronic complications, it is necessary to develop an individualized, patient-centered treatment strategy, activate insulin therapy according to the condition, and accordingly adopt an individualized pharmacological strategy in the process of insulin therapy, not only to avoid "inertia", but also to avoid "abuse", pay attention to the role of new hypoglycemic drugs. That said, most people with type 2 diabetes are likely to apply insulin.
So how is insulin currently being used? According to the reporter's understanding, insulin collection will be implemented throughout the country in May, and the biggest benefit to patients is that the price has dropped, and the followed insulin treatment choices will also undergo great changes.
Insulin therapy may be cheaper than some oral hypoglycemic drugs
Insulin collection will be implemented throughout the country in May. According to the price of the e-commerce platform, before the collection, the price of the single spermin zinc recombinant lispro insulin mixed injection (25R) is about 70 yuan, the aspart 30 injection is about 75 yuan, and the insulin glargine injection is about 140 yuan, if calculated according to the number of 3 insulins used per month, the daily expenses of patients are nearly 7-14 yuan.
After the collection, Shanghai Sunshine Pharmaceutical Procurement Network showed that the sperm protein zinc recombinant lispro insulin mixed injection (25R) dropped to 18.89 yuan, insulin aspart 30 injection was 43.2 yuan, and insulin glargine injection was 48.71 yuan. The daily treatment cost of sperm protein zinc recombinant lispro insulin mixed injection (25R) is less than 2 yuan, which is cheaper than some oral hypoglycemic drugs.
In addition to the price, the trust of doctors and patients will also be greatly improved, the reporter interviewed a sugar friend, he said: "In the past, the profit margin of drugs will make patients doubt the purpose of doctors prescribing drugs, affect the mutual trust between doctors and patients, reduce patient compliance, and is not conducive to their own control and treatment." After the collection, the gap between doctors and patients is of course further reduced, which in itself is also conducive to the improvement of treatment compliance and the improvement of the condition. This will also allow doctors to lighten up and reduce the psychological burden. ”
Patients are about to experience better insulin
"In the past, we did not conduct a comparative study between primary and non-primary insulin. We know that the biggest difference between the two is not efficacy, but convenience. Therefore, even if the insulin is not collected and reduced in price, we will recommend the original research insulin to the patient, the purpose is to make the patient comfortable, the medical treatment is comfortable, and the treatment is comfortable. Now, the collection of insulin prices has been reduced, and patients have the ability to use insulin with a better sense of experience, which is a great impetus for compliance and the improvement of blood glucose control rates. Professor Qin Guijun, director of the Department of Endocrinology of the First Affiliated Hospital of Zhengzhou University, pointed out.
At the time of the implementation of the national procurement, many patients will wonder if they switch drugs now, will there be blood sugar fluctuations? Ji Linong, director of the Department of Endocrinology at Peking University People's Hospital, pointed out, "On the basis of good blood sugar control, the same type of insulin, such as between fast-acting insulin and fast-acting insulin, between premixed insulin and premixed insulin, can be interchanged." However, we should pay attention to the fact that after switching insulin, doctors and patients should do a good job of blood glucose monitoring, adjust the dose in time according to changes in islet function and blood sugar changes, and avoid blood sugar fluctuations after switching insulin. (For more news, please pay attention to Yangcheng Pie pai.ycwb.com)
Source | Yangcheng Evening News Yangcheng Pie
Editor-in-charge | Cui Wencan